D.E. Shaw & Co
PHAT icon

D.E. Shaw & Co’s Phathom Pharmaceuticals PHAT Stock Holding History

D.E. Shaw & Co’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Sell
132,457
-128,611
-49% -$1.62M ﹤0.01% 3153
2025
Q4 		$4.33M Buy
+261,068
New +$3.73M ﹤0.01% 2430
2024
Q4 		– Sell
-143,707
Closed -$2.6M – 4791
2024
Q3 		$2.6M Buy
+143,707
New +$2.01M ﹤0.01% 2493
2024
Q2 		– Sell
-64,138
Closed -$681K – 4815
2024
Q1 		$681K Sell
64,138
-65,251
-50% -$554K ﹤0.01% 3322
2023
Q4 		$1.18M Sell
129,389
-1,175
-0.9% -$10.1K ﹤0.01% 3028
2023
Q3 		$1.35M Buy
130,564
+16,871
+15% +$231K ﹤0.01% 2874
2023
Q2 		$1.63M Buy
+113,693
New +$1.31M ﹤0.01% 2766
2022
Q4 		– Sell
-14,477
Closed -$160K – 5082
2022
Q3 		$160K Sell
14,477
-47,781
-77% -$455K ﹤0.01% 4526
2022
Q2 		$525K Buy
+62,258
New +$640K ﹤0.01% 4061
2020
Q1 		– Sell
-7,528
Closed -$234K – 4204
2019
Q4 		$234K Buy
+7,528
New +$189K ﹤0.01% 3734

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return